Wednesday, April 19, 2023 9:10:55 AM
R-Three Technologies, Inc. (OTCMKTS:RRRT)
NEW YORK CITY, NEW YORK, USA, April 19, 2023/EINPresswire.com/ -- The past few weeks for R-Three Technologies Inc. has been very busy and productive. We have restructured our team and made a number of changes that set the foundation for the company to build and grow.
“Compliance and growth are the main focus as we aim to deliver for our shareholders” said Nicholas Greeff, company President. “As I take this opportunity to lead in building this company, we are focused on making sure that we are compliant and that we are operating from a solid foundation for our shareholders”.
In the past 5 weeks we have accomplished the following,
- Nicholas Greeff was appointed President and Director
- Restructured leadership team.
- Notified OTC of our changes and gained access to OTCIQ
- Built a new company website, www.r-threetechnologies.com
- Established a formal line of communication through,
contact@r-threetech.com
- Launched a new twitter channel, @R_ThreeTechInc
- Returned 372, 947, 829 Common Shares to the treasury
- Established new corporate guidelines and procedures focusing on compliance.
- Appointed Kenneth R. Pinckard as General Legal Counsel
- Filed Annual 10K Report and Disclosures
The return of common shares to the treasury R-Three Technologies has made room for new possibilities. We are in the process of building a new plan and will keep shareholders up to date as new information becomes available. While doing so the company is also in a senior management recruitment stage.
“We have significant and realistic plans for R-Three Technologies. With our shareholders’ support we will take the company to new heights,” said Nicholas Greeff
On behalf of R-Three Technologies Inc.
Nicholas Greeff, President and Director
contact@r-threetech.com
https://twitter.com/einpresswirepr/status/1648672928618147840?s=46&t=42-7u4_sbSmAVDNhwVSDOg
If you haven't learned yet, most posts on a message board are in the writer's opinion. All of my posts are in my opinion (IMO)......do your Due Diligence (DD) and make up your own mind!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM